In the BioHarmony Drug Report Database
Cefepime
Cefepime, Maxipime (cefepime) is a small molecule pharmaceutical. Cefepime was first approved as Cefepime on 1996-01-18. It is used to treat acinetobacter infections, bacterial infections, bacterial pneumonia, bacterial skin diseases, and bacteroides infections amongst others in the USA.
Trade Name
|
Cefepime, Maxipime |
|---|---|
Common Name
|
cefepime |
ChEMBL ID
|
CHEMBL186 |
Indication
|
acinetobacter infections, bacterial infections, bacterial pneumonia, bacterial skin diseases, bacteroides infections, escherichia coli infections, fever, haemophilus infections, infectious bone diseases, klebsiella infections, neutropenia, proteus infections, pseudomonas infections, pyelonephritis, sepsis, serratia infections, soft tissue infections, staphylococcal infections, streptococcal infections, urinary tract infections |
Drug Class
|
Cephalosporins |
Image (chem structure or protein)